Know which KOLs in pharma shape opinion in your therapy area, how they read the emerging data, and what they need answered before they change practice.

Evidence plans built without expert input answer questions the field stopped asking, and miss the ones it is asking now.
See where experts agree, where they split and what would change their minds.
Point evidence generation at the questions experts say are still open.
Medical communication focuses on the points experts find unclear or unconvincing.
KOL mapping is the work of identifying the key opinion leaders (KOLs) in a therapy area and understanding where they stand on the science, the unmet need and the emerging data. Nextyn runs moderated interviews with KOLs and practicing physicians and maps where they agree, where they split and which scientific questions they still consider open.

What you will knowHow new data is being received by KOLs and practicing physicians, and which doubts remain.

What you will knowThe questions experts want answered before they change practice, ranked by how widely they are raised.

What you will knowThe topics that need clearer evidence or explanation, and the order to address them in.





What it settledIn-depth interviews with KOLs and practicing oncologists assessed the perceived differentiation of upcoming Phase III data, likely shifts in treatment algorithms and the scientific questions that remained unresolved, informing medical communications priorities.
Read the case study


Send us your question. We come back with a plan and a price. Nothing starts until you approve it.
What you need to know, which markets, and by when.
Who we will speak to, how, and what it costs. Inside 48 hours.
Nothing is commissioned until you say yes.
Every interview read together: where they agree, where they conflict, and what is still open.
KOL mapping is the work of identifying the key opinion leaders who shape thinking in a therapy area and understanding where each one stands on the science. KOL stands for key opinion leader, an expert whose views shape thinking in a therapy area. Insight-led mapping also records how experts read new data, where they agree and split, and which scientific questions they still consider open. Nextyn builds the map from moderated interviews with KOLs and practicing physicians in the United States and Europe.
A Nextyn KOL and scientific insight study delivers three outputs: a map of the experts who shape opinion in the therapy area, their views summarized by scientific topic, and a ranked list of evidence gaps and communication priorities. Each output comes from moderated interviews, not publication counts:
Nextyn interviews three groups of experts for KOL mapping, from KOL doctors to practicing physicians: national and international KOLs, regional and rising experts, and the practicing physicians who apply the science day to day. The profile and markets are agreed at scoping around the therapy area:
Nextyn runs KOL mapping in the United States, the United Kingdom, Germany, France, Italy and Spain, among other markets. Markets are agreed at scoping, because the experts who shape practice in one country are not always the ones who shape it in the next. Recent Nextyn work includes in-depth interviews with KOLs and practicing oncologists in France on how upcoming Phase III data would shift treatment algorithms, and KOL and payer interviews on unmet need in Spain.
Nextyn recommends KOL mapping when new data is emerging in a therapy area, and before an evidence plan or scientific narrative is set. Expert views captured at that point keep new studies and medical messages focused on the questions the field is asking now. There are three other triggers for a fresh map: a competitor readout, a guideline revision and an expansion into new markets.
A Nextyn KOL mapping project runs in four steps, from brief to read-out, and nothing is commissioned until the client approves the plan. The client sees the expert profile, method and price before any fieldwork, and reads every interview with the Nextyn team at the end.
Nextyn sends a research plan within 48 hours of receiving the brief, stating which experts will be interviewed, how, and what the work costs. The plan sets the fieldwork length for the therapy area, the expert profile and the markets in scope, so a single-country read and a US and EU4 map each get their own timeline. Nothing is commissioned until the client approves that plan and its price.
Nextyn's KOL mapping records what experts think about the science, in moderated interviews, while a publication-based KOL database ranks experts by publications, citations and congress activity. The database shows who is visible, and interviews show where each expert stands and which questions they still consider open.
| Nextyn KOL mapping | Publication-based KOL database | |
|---|---|---|
| Scope | One therapy area and its open questions | Every author in a field |
| Evidence | Moderated interviews with KOLs and practicing physicians | Publications, citations and congress records |
| Output | Expert map, topic summary and evidence priorities | Ranked lists of names and influence scores |
| Timing | A research plan in 48 hours, then fieldwork to the evidence plan | Updated on the vendor's schedule |
Your privacy choices
We measure how this site is used and which campaigns bring people here. You can opt out at any time, which also stops any sale or sharing of your personal information for advertising.
Needed for the site to work — your session and your privacy choice itself. Always on.
How pages are found and read, so we can improve them. Never sold, never used to advertise to you.
Records how you move through a page so we can see what is confusing. Typing is masked, and the chat panel and every form are never recorded.
Lets us measure which campaigns bring people here, and show relevant messages elsewhere.